CG Oncology has taken the ribbon for the first biotech initial public offering (IPO) of the new year and its $380 million raise – which far outstrips the proceeds forecast – backs up the view that a recovery in the sector is on the way.
Copyright © 2024 | WordPress Theme by MH Themes